Comparative Study on the Effect of Quadratus Lumborum Block Versus Intrathecal Morphine on the Incidence of Chronic Pain Post Caesarean Section
CompletedNot applicableNCT05602038
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to compare the incidence of CPSCP in patients receiving QLB quadratus lumborum block and ITM versus control as a primary outcome and associated risk factors that might predispose patients to develop CPSCP.
Study details
- Official title
- Quadratus Lumborum Block Versus Intrathecal Morphine for Prevention of Chronic Post-Caesarean Pain: A Four-Arm Randomised Controlled Trial
- Conditions
- Chronic Post Cesarean Pain
- Interventions
- Procedure: Quadratus laborum block
- Drug: Intrathecal morphine
- Drug: intrathecal bupivacaine
- Sponsor
- Menoufia University
- Start date
- 2023-02-01
- Primary completion
- 2023-12-01
- Sex
- Female
- Age range
- from 18 Years to 45 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients admitted to the operating theatre for elective caesarean section Exclusion Criteria: * lack of informed consent * Allergy to drugs used during the study * Depression and epilepsy that required antidepressants or anticonvulsants * known coagulopathy as a contraindication for spinal anesthesia
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05602038